Aarti Pharmalabs Limited
AARTIPHARM · NSE · ₹968 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Aarti Pharmalabs Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 38.7%; Net profit was ₹76.14 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹536 cr | +38.7% | Net profit: ₹76 cr | +53.8% | 14.2% | Company filing source |
| Mar 2026 | Revenue: ₹583 cr | +3.3% | Net profit: ₹61 cr | -30.8% | 10.5% | Company filing source |
| Dec 2025 | Revenue: ₹432 cr | — | Net profit: ₹48 cr | — | 11.1% | Company filing source |
| Sep 2025 | Revenue: ₹418 cr | — | Net profit: ₹28 cr | — | 6.7% | Company filing source |
| Jun 2025 | Revenue: ₹386 cr | -30.5% | Net profit: ₹50 cr | -10.7% | 12.8% | Company filing source |
| Mar 2025 | Revenue: ₹564 cr | — | Net profit: ₹88 cr | — | 15.7% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Life Insurance Corporation Of India 5.3%Rashesh Chandrakant Gogri 4.2%Jaya Chandrakant Gogri 3.5%Anushakti Enterprise Private Limited 3.3%LABDHI BUSINESS TRUST(Saswat Trusteeship Private Limited) 3.1%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- General Updates. Aarti Pharmalabs Limited has informed the Exchange about Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Require…
30 Sep 2026 · document
- Updates. Aarti Pharmalabs Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI Listing Regulations- Reconstitution of Committee o…
30 Sep 2026 · document
- Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
28 Sep 2026 · document
- Aarti Pharmalabs Limited has informed the Exchange regarding 'Updates on Change in Directorate'.…
23 Sep 2026 · document
- Shareholders meeting. Aarti Pharmalabs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Furthe…
23 Sep 2026 · document
- Updates. Aarti Pharmalabs Limited has informed the Exchange regarding 'Presentation made to the shareholders at 7th AGM'.…
22 Sep 2026 · document
- Shareholders meeting. Aarti Pharmalabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026…
22 Sep 2026 · document
- Aarti Pharmalabs Limited has informed the Exchange about General Updates…
02 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time